An FDA advisory committee has rebuffed a drug called "female Viagra", which was made to boost the sexual desire of pre-menopausal women.

According to the specialists on the jury, the drug flibanserin made by German drug manufacturer, Boehringer Ingelheim was not effectual.

FDA panelist, Paula Hillard, a Gynecologist from Stanford University School of Medicine, said, "I am convinced that women's sexual health is important and that many women suffer from sexual dysfunction, but I'm not convinced of a clinically meaningful benefit for this drug".

Specialists observed that the firm had discontinued utilizing an assessment scale for trailing women's sexual experiences, whilst utilizing the medicine after they discovered uninspiring outcomes.

The FDA also based its denial of the medication on its side results together with tiredness, depression and fainting spells that they deem to offset the minor rise in sexual receptiveness and fulfillment, which the serotonin-controlling medicine generated in women.

Lack of libido is as widespread as it is upsetting, particularly if you were once awash with sexual desire. But the answer to rectify it is not a tablet.

Viagra provides males erections. But the lack of libido is not about incapability to have sexual intercourse; it's about a total loss of interest in the activity.

The drug might be of use to those women, who have a shortage of genital blood flow and lubrication, i. e. those with Female Sexual Arousal Disorder (FSAD).